Market Scope uses a multi-source methodology when preparing our annual and quarterly reports. We incorporate surgeon surveys, our extensive database of physicians and surgery centers, disease models, clinical studies, financial reports, and more. Our wide-ranging knowledge of products and technology and our comprehensive network of industry contacts also contribute to our coverage on the ophthalmic industry.
The “2025 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 12 categories of IOLs: commodity monofocal, enhanced monofocal, intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, post-op adjustable, and phakic IOLs. Additionally, 35 companies are profiled, with discussion of their products, strategic market position, background, and outlook.
Our coverage of the cataract surgery market includes a quarterly surveying process that targets and collects data from US cataract surgeons. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Cataract Editions. These editions are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends.
Market Scope’s "2025 United States Cataract Surgeon Survey Report" offers deep insights into the evolving cataract surgery market, with data collected from 125 ophthalmic surgeons representing more than 1,000 practitioners across single and group practices.
Conducted in March and April 2025, the survey explores key aspects of cataract surgery—including practice characteristics, surgical techniques, product preferences, and marketing strategies. It features expanded coverage on critical topics such as presbyopia-correcting IOLs (PC-IOLs), toric and EDOF IOLs, astigmatism correction, femtosecond laser-assisted cataract surgery (FLACS), surgical settings, and interest in emerging technologies and equipment.
The report delivers detailed market share analysis by manufacturer, product, and market segment, as well as insights into the use and management of MIGS devices and glaucoma treatments.
Sponsored by leading ophthalmic companies, this report is designed to help industry stakeholders better understand market dynamics, surgeon preferences, and future trends—making it an essential resource for strategic planning and product development.
Market Scope's first-edition "2025 Presbyopia Survey Report" provides pivotal insights into treatment methods, adoption plans, average pricing, and emerging technologies shaping the presbyopia landscape. From drops to presbyopia-correcting IOLs, this report delivers survey data essential for informed decision-making in ophthalmic care. Whether you're a healthcare provider, researcher, or investor, leverage this report to navigate the evolving presbyopia market with confidence.
Market Scope has published the Ophthalmic Market Perspectives (OMP) newsletter for more than 20 years. The newsletter provides the latest business information that is shaping ophthalmic markets and professions. Our articles explore new technologies and company developments. We offer opinions on issues facing the industry. We also analyze and chart quarterly industry data, and we forecast market performance over time.
Market Scope’s “2025 European Five Ophthalmic Market Report” dives into Western Europe’s top five ophthalmic markets—France, Germany, Italy, Spain, and the United Kingdom—exploring 11 ophthalmic submarkets with insights on crucial trends and factors for success. The report reviews current market landscapes, projects market performance through 2030, forecasts disease prevalence, analyzes treatment volumes, and reviews emerging technologies and profiles key competitors.
The “2024 Ophthalmic Landscape Report” offers a high-level analysis of the ophthalmic market by region and subspecialty and forecasts market performance of nine product categories through 2029. The report analyzes important trends, reviews key factors for future success, comprehensively details the competitive landscape in ophthalmology, and compares the ophthalmic sector across health care and other related markets.
The “2025 Glaucoma Pharmaceuticals Market Report” analyzes the global and regional markets for glaucoma pharmaceuticals, identifying important trends and key factors for future success. The report provides forecasts through 2030 for branded prostaglandins, generic prostaglandins, beta blockers, carbonic anhydrase inhibitors, alpha agonists, fixed combo drugs, NO-donating compounds, and Rho-kinase inhibitors. The report also extensively discusses pipeline products, covering over 30 drug candidates that are currently under development. Additionally, 25 glaucoma pharmaceutical companies are profiled, with discussion of their products, strategic market position, background, and outlook.
The “2024 Ophthalmic Laser Market Report” offers a comprehensive analysis of the global market for ophthalmic lasers, as well as a discussion of important trends and key factors shaping future success. The report covers photocoagulation, photodisruption, and SLT lasers with market data for 2023 and forecasts through 2029. Product demand is forecast in units and dollars, and market share is analyzed by product category. Seventeen market competitors are profiled, with discussion of their products, strategic market position, background, and outlook.
This report is designed for ophthalmic industry manufacturers, market analysts, providers, and investors who are interested in the ophthalmic lasers business and related products. In-depth topics include laser treatment estimates, ophthalmic surgeons using lasers, and manufacturers of ophthalmic lasers (excluding femtosecond and excimer lasers).
The “2025 Retinal Device Market Report” provides in-depth analysis of the global retinal device market, examining the market’s size and growth, as well as identifying important developments that may shape its future. The analysis focuses on the 2024 market and forecasts market growth and evolution through 2029. Additionally, 19 retina device companies are profiled, with discussion of their products, strategic market position, background, and outlook.
In addition to our standard comprehensive reports, we also leverage our expert knowledge of the ophthalmic industry to design custom research that enhances strategy and operations for our clients. Our unique experience makes us a trusted partner in defining problems and executing solutions.
Common project types include custom data analysis, surveying and/or interviewing of ophthalmologists, focus groups, territory analyses, and other primary research initiatives -- but each project is custom designed to meet each specific clients' needs.
Please contact us for an individualized project consultation.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.